Weekly Winners | Omnicom Soars 21%; Moderna Surges 18%; Garmin Jumps 16%

This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.

Below are top 10 S&P 500 stock gainers for the week ended Feb. 20:

Omnicom Jumps on Dividend, $5-Billion Buyback

Omnicom jumped 20.67% this week to finish at $80.94 apiece as investors gobbled up amid efforts to boost shareholder value through dividends and a $5 billion share buyback program.

In an announcement during the day, Omnicom said that it would distribute $0.80 worth of dividends to all common shareholders on record as of March 11, payable on April 9, 2026.

This is on top of its authorized share buyback program, under which a number of financial institutions agreed to sell back to the company a total of $2.5 billion of Omnicom shares. An initial delivery will be made by Friday, February 20, with the rest expected by the second quarter of the year.

Global Payments Stock Surges After Introducing Strong Guidance, $2.5B Buyback

Global Payments stock surged 20.43% this week after the payments technology firm issued a robust outlook for 2026 and its board authorized up to $2.5B of stock buybacks, including a $550M accelerated share repurchase plan.

The company expects 2026 adjusted EPS of $13.80-$14.00, or growth of 13%-15%. That's stronger than the average analyst estimate of $13.78. Constant currency adjusted net revenue is expected to grow ~5%, excluding disposition, vs. 1.8% growth in 2025. Its adjusted operating margin is projected to expand by ~150 basis points.

During Q4 2025, Global Payments (GPN) completed its acquisition of Worldpay and its divestiture of Issuer Solutions, repositioning the company as a pure-play merchant solutions provider, it said.

Moderna Stock Surges as FDA Reverses Course, Agrees to Review New Flu Shot

Moderna stock jumped 18.09% this week after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject the review last week.

Moderna recently developed a new flu vaccine using the same mRNA technique that underpins its COVID-19 vaccine. But after requesting review from the federal government, the FDA initially declined to review the drug — a necessary regulatory step toward bringing the drug to market — saying that it wasn't satisfied with Moderna's trials.

On Wednesday morning, however, Moderna announced in a press release that the FDA had reversed course and agreed to review the drug.

Garmin Stock Surges. There’s More to Its Move Than Solid Earnings

Garmin stock spiked 15.91% this week after the maker of smartwatches and navigation tools posted strong fourth-quarter earnings and issued an upbeat forecast for 2026.

The company’s 2026 outlook also blew past consensus views. Garmin sees pro forma earnings of $9.35 a share, while analysts tracked by FactSet were expecting $8.78. The company told investors to expect $7.9 billion in revenue for 2026, above calls for $7.7 billion.

Other factors appeared to be driving the stock higher, including a proposed 17% dividend hike. Garmin said its board will urge shareholders to approve a quarterly dividend increase to $1.05 from 90 cents at their annual meeting in June.

Texas Pacific Land Stock Jumps After Record 2025 Results, Bigger Dividend

Texas Pacific Land shares surged about 15.63% this week, as the company posted full-year highs in both revenue and cash flow.

The company lifted its quarterly dividend by 12.5%, crediting a fresh royalty-acre deal and a new data-center infrastructure investment.

Texas Pacific Land Corporation posted net income of $123.3 million, or $1.79 per diluted share, on $211.6 million in revenue for the fourth quarter, per results released late Wednesday. For 2025, net income landed at $481.4 million with total revenue of $798.2 million, and free cash flow after capex came to $498.3 million. CEO Tyler Glover called it “an excellent finish to a record year” and pointed to “next-generation opportunities in data centers and produced water desalination.”

Norwegian Cruise Line Jumps on Activist Investor Stake, Turnaround Plans

Norwegian Cruise Line shares rallied 13.12% this week, after activist investment firm Elliott Investment Management bought a material stake in the cruise operator.

Elliott Investment Management bought a 10% stake in Norwegian Cruise Line, the Wall Street Journal reported, with plans to improve operations to better compete with rivals Royal Caribbean and Carnival. That would make Elliott Investment the third-largest holder of NCLH stock, according to FactSet data.

Elliott Investment regularly buys in to companies with plans to make a profit by improving operations. The company last year won a fight for board seats at Phillips 66 and purchased a $4 billion stake in PepsiCo. In 2024 it bought a significant stake in Southwest Airlines to help turn it around.

Occidental Petroleum Tops Quarterly Profit Estimates on Midstream Support

Occidental beat Wall Street expectations for fourth-quarter profit on Wednesday, as strength in its midstream unit helped the U.S. shale producer offset weaker crude oil prices.

Shares of the company rose 12.52% this week.

Occidental's realized oil prices fell to $59.22 per barrel in the fourth quarter, from $69.73 a year earlier, though production rose slightly to 1.48 million barrels (MMboepd) of oil equivalent per day.